ATRI Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 22.82%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Atrion Insider Trading History Chart

This chart shows the insider buying and selling history at Atrion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Atrion Share Price & Price History

Current Price: $459.92
Price Change: +0.30 (1.20%)
As of 08/21/2024 01:00 AM ET

This chart shows the closing price history over time for ATRI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Atrion Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Atrion (NASDAQ:ATRI)

66.19% of Atrion stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATRI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$40M-$20M$0$20M$40MTotal InflowsTotal Outflows
Atrion logo
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Read More on Atrion

Today's Range

Now: $459.92
Low: $459.92
High: $459.92

50 Day Range

MA: $459.06
Low: $456.25
High: $459.92

52 Week Range

Now: $459.92
Low: $274.98
High: $503.24

Volume

N/A

Average Volume

23,283 shs

Market Capitalization

$809.46 million

P/E Ratio

43.23

Dividend Yield

1.91%

Beta

0.69

Who are the company insiders with the largest holdings of Atrion?

Atrion's top insider investors include:
  1. David A Battat (CEO)
  2. Preston G Athey (Director)
Learn More about top insider investors at Atrion.